6 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptomsdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-09-25NCT06559306
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsBipolar and Related Disorders, bipolar disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-09-25NCT06372964
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderBipolar and Related Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, autism spectrum disorder, bipolar disorder, mood disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, schizophreniaRecruitingPhase 32026-09-25NCT06229210
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderSchizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophreniaRecruitingPhase 32026-08-14NCT05303064
Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsSchizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophreniaEnrolling by invitationPhase 32026-08-14NCT04987229
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32025-10-08NCT03817502